Psychosis: Pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

Trends in Neurosciences

Volumn 24, Issue 6, 2001, Pages 330-334

  Sharp, Frank R ^a   Tomitaka, Midori ^b   Bernaudin, Myriam ^a   Tomitaka, Schinichiro ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CLOZAPINE; DIZOCILPINE; HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PHENCYCLIDINE; PSYCHEDELIC AGENT;

BRAIN INJURY; CINGULATE GYRUS; DRUG EFFECT; HUMAN; LIMBIC CORTEX; NERVE CELL; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; THALAMUS;

ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; HUMANS; LIMBIC SYSTEM; MODELS, NEUROLOGICAL; PSYCHOSES, SUBSTANCE-INDUCED; RECEPTORS, GABA; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; THALAMUS;

EID: 0035370757     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01817-8     Document Type: Review

References (62)

1. J.H Krystal NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders Harv. Rev. Psychiatry 7 1999 125 143
2. J.W Olney Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs Science 244 1989 1360 1362
3. S Tomitaka Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex Eur. J. Neurosci. 12 2000 1420 1430
4. R.N Auer Assessing structural changes in the brain to evaluate neurotoxicological effects of NMDA receptor antagonists Psychopharmacol. Bull. 30 1994 585 591
5. F.R Sharp MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex Ann. Neurol. 30 1991 801 809
6. F.R Sharp Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine J. Neurosci. Res. 33 1992 605 616
7. F.R Sharp Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels Neuroscience 62 1994 1079 1092
8. I.J Mitchell Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis? Neuroscience 84 1998 489 501
9. J.W Olney NMDA antagonist neurotoxicity: mechanism and prevention Science 254 1991 1515 1518
10. J.W Olney Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity J. Clin. Psychiatry (Suppl. B) 55 1994 43 46
11. N.B Farber Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity Biol. Psychiatry 34 1993 119 121
12. N.B Farber Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity Schizophr. Res. 21 1996 33 37
13. J.W Olney Neurotoxicity of NMDA receptor antagonists: an overview Psychopharmacol. Bull. 30 1994 533 540
14. A Gonzalo-Ruiz Evidence for collateral projections to retrosplenial granular cortex and thalamic reticular nucleus from glutamate and/or aspartate-containing neurons of the anterior thalamic nuclei in the rat Exp. Brain Res. 116 1997 63 72
15. E.G Jones A new view of specific and nonspecific thalamocortical connections Adv. Neurol. 77 1998 49 71
16. R.W Guillery Paying attention to the thalamic reticular nucleus Trends Neurosci. 21 1998 28 32
17. E.G Jones Nucleus- and cell-specific expression of NMDA and non-NMDA receptor subunits in monkey thalamus J. Comp. Neurol. 397 1998 371 393
18. B Moghaddam Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352
19. Y Yonezawa Involvement of γ-amino butyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex Eur. J. Pharmacol. 341 1998 45 56
20. H.C Grunze NMDA-dependent modulation of CA1 local circuit inhibition J. Neurosci. 16 1996 2034 2043
21. I Feinberg Intraperitoneal dizocilpine induces cortical spike-wave seizure discharges in rats Neurosci. Lett. 196 1995 157 160
22. G.E Duncan Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism J. Pharmacol. Exp. Ther. 293 2000 8 14
23. F.X Vollenweider Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) Eur. J. Neuropsychopharmacol. 7 1997 25 38
24. J.W Olney NMDA receptor hypofunction model of schizophrenia J. Psychiatr. Res. 33 1999 523 533
25. C Missale Dopamine receptors: from structure to function Physiol. Rev. 78 1998 189 225
26. L Mrzljak Localization of dopamine D4 receptors in GABAergic neurons of the primate brain Nature 381 1996 245 248
27. P.S Goldman-Rakic D(1) receptors in prefrontal cells and circuits Brain Res. Rev. 31 2000 295 301
28. R.A Wise Addictive drugs and brain stimulation reward Annu. Rev. Neurosci. 19 1996 319 340
29. T.H Svensson Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs Brain Res. Rev. 31 2000 320 329
30. S.I Tomitaka Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70 Brain Res. 763 1997 255 258
31. N.B Farber Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity Neuropsychopharmacology 18 1998 57 62
32. J.W Sharp Effects of sigma ligands on the ability of rimcazole to inhibit PCP hsp70 induction Brain Res. Bull. 39 1996 359 366
33. Farber, N.B. et al. Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol. Psychiatry (in press)
34. J.W Sharp DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex Brain Res. 687 1995 114 124
35. D.C Javitt Recent advances in the phencyclidine model of schizophrenia Am. J. Psychiatry 148 1991 1301 1308
36. R.N Auer Effect of age and sex on N-methyl- d -aspartate antagonist-induced neuronal necrosis in rats Stroke 27 1996 743 746
37. J.L Rapoport Childhood-onset schizophrenia. Progressive ventricular change during adolescence Arch. Gen. Psychiatry 54 1997 897 903
38. F.X Vollenweider Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) Eur. Neuropsychopharmacol. 7 1997 25 38
39. C.A Tamminga The limbic cortex in schizophrenia: focus on the anterior cingulate Brain Res. Rev. 31 2000 364 370
40. Tamminga, C. (1999) Glutamatergic aspects of schizophrenia. Br. J. Psychiatry (Suppl.) 12–15
41. N.C Andreasen Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients Lancet 349 1997 1730 1734
42. D.C Goff A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia Biol. Psychiatry 45 1999 512 514
43. S.S Shergill Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging Arch. Gen. Psychiatry 57 2000 1033 1038
44. N.C Andreasen The role of the thalamus in schizophrenia Can. J. Psychiatry 42 1997 27 33
45. W.G Staal Partial volume decrease of the thalamus in relatives of patients with schizophrenia Am. J. Psychiatry 155 1998 1784 1786
46. J.J Thune Stereological studies of the schizophrenic brain Brain Res. Rev. 31 2000 200 204
47. L.C Konick Meta-analysis of thalamic size in schizophrenia Biol. Psychiatry 49 2001 28 38
48. U Ettinger Magnetic resonance imaging of the thalamus in first-episode psychosis Am. J. Psychiatry 158 2001 116 118
49. P Danos Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons Psychiatry Res. 82 1998 1 10
50. G.J Popken Subnucleus-specific loss of neurons in medial thalamus of schizophrenics Proc. Natl. Acad. Sci. USA 97 2000 9276 9280
51. K.A Young Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia Biol. Psychiatry 47 2000 944 953
52. M.M Huntsman Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the γ amino butyrate type A receptor in prefrontal cortex of schizophrenics Proc. Natl. Acad. Sci. USA 95 1998 15066 15071
53. D.W Volk GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons Am. J. Psychiatry 158 2001 256 265
54. P.J Harrison The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593 624
55. A.A Wassef Critical review of GABAergic drugs in the treatment of schizophrenia J. Clin. Psychopharmacol. 19 1999 222 232
56. G.K Aghajanian Serotonin model of schizophrenia: emerging role of glutamate mechanisms Brain Res. Rev. 31 2000 302 312
57. L.H Lindstrom Schizophrenia, the dopamine hypothesis and alpha2-adrenoceptor antagonists Trends Pharmacol. Sci. 21 2000 198 199
58. A.A Grace Gating of information flow within the limbic system and the pathophysiology of schizophrenia Brain Res. Rev. 31 2000 330 341
59. S Rajdev Acute phencyclidine neurotoxicity in rat forebrain: induction of haem oxygenase-1 and attenuation by the antioxidant dimethylthiourea Eur. J. Neurosci. 10 1998 3840 3852
60. A Carlsson Network interactions in schizophrenia – therapeutic implications Brain Res. Rev. 31 2000 342 349
61. F.M Benes Emerging principles of altered neural circuitry in schizophrenia Brain Res. Rev. 31 2000 251 269
62. D.A Lewis GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia Brain Res. Rev. 31 2000 270 276